Santos-Venâncio Miguel, Rocha-Neves João, Spath Paolo, Oliveira-Pinto José
Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Biomedicine - Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; RISE@Health, Porto, Portugal.
Ann Vasc Surg. 2024 Jul 25;109:433-443. doi: 10.1016/j.avsg.2024.06.030. eCollection 2024 Dec.
Catheterization of target vessels (TV) represented by renal visceral vessels are the crucial aspect during fenestrated and branched endovascular repair. This study aims to assess the efficacy and complications associated with upper limb catheterization during complex aneurysm endovascular surgery repair.
A systematic review was conducted after Preferred Reporting Items for a Systematic Review and Meta-analysis (PRISMA) guidelines, involving a search across PubMed, Cochrane CENTRAL, and Web of Science. Primary endpoint was represented by 30-day stroke. Secondary endpoints were target vessels' (TVs) technical success, 30-day mortality, and local access-related complications. Meta-analyses were performed using a random-effects model.
Sixteen observational studies encompassing 4,137 patients were included. The 30-day stroke incidence for upper limb access was 1.4% (95% CI 1.0-1.8%), which was slightly higher than lower limb, despite not statistically significant. Mortality varied between 0 and 6.8%, and local access-related complications occurred in 3.2% (95% CI 1.9-4.4%). Technical success in TV catheterization was 99.2% (95% CI 98.4-100.0%).
This systematic review and meta-analysis demonstrate the safety and efficacy of upper limb access for Fenestrated and Branched Endovascular Aortic Repair (f/b-EVAR), with low stroke risk, mortality rates, and minimal local complications. Despite the risk of bias, the findings suggest that upper limb access may be beneficial, especially in bailout situations when femoral access fails, offering valuable insights for clinical decision-making.
以肾内脏血管为代表的靶血管插管是开窗和分支血管腔内修复术中的关键环节。本研究旨在评估复杂动脉瘤血管腔内手术修复过程中上肢插管的疗效及并发症。
按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行系统评价,检索了PubMed、Cochrane CENTRAL和Web of Science数据库。主要终点为30天卒中发生率。次要终点为靶血管的技术成功率、30天死亡率和局部穿刺相关并发症。采用随机效应模型进行Meta分析。
纳入16项观察性研究,共4137例患者。上肢穿刺的30天卒中发生率为1.4%(95%CI 1.0-1.8%),略高于下肢,但差异无统计学意义。死亡率在0%至6.8%之间,局部穿刺相关并发症发生率为3.2%(95%CI 1.9-4.4%)。靶血管插管的技术成功率为99.2%(95%CI 98.4-100.0%)。
本系统评价和Meta分析表明,上肢穿刺用于开窗和分支血管腔内主动脉修复(f/b-EVAR)具有安全性和有效性,卒中风险、死亡率低,局部并发症极少。尽管存在偏倚风险,但研究结果表明上肢穿刺可能有益,尤其是在股动脉穿刺失败的补救情况下,为临床决策提供了有价值的见解。